Oral dydrogesterone for prevention of miscarriage in threatened miscarriage: a randomized, double-blind, placebo-controlled trial

Volume 37, Issue 1, December 2024 .

Source: Journal of Maternal-Fetal and Neonatal Medicine - April 4, 2024 Category: Perinatology & Neonatology Authors: Arissara KuptarakVorapong PhupongDepartment of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, Thailand Source Type: research